United Neuroscience to Present at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics
DUBLIN, Feb. 28, 2018 /PRNewswire/ -- United Neuroscience, Ltd., (UNS), today announced that the company will present at the upcoming 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT) conference being held March 7-10, 2018. Presentation details are as follows:
Symposium presentation: Active immunotherapy vaccines for CNS disorders Presenter: Ajay Verma, M.D., Ph.D., Chief Medical Officer Date: Friday, March 9, 2018 Time: 10:15 a.m. EST Poster presentation: A Phase 2a, randomized, double-blind, placebo-controlled, 3-arm parallel-group, multicenter study with active immunotherapeutic vaccine UB-311 in patients with mild Alzheimer's disease Time: Thursday, March 8, 3:45 p.m. EST and Friday, March 9, 4:15 p.m. EST Location: Hilton Washington D.C./Rockville Hotel, Rockville, MD
About United Neuroscience
United Neuroscience (UNS) is a clinical-stage biotech company dedicated to the development of best-in-class immunotherapeutics for the brain. A global company headquartered in Dublin, Ireland, with operations in Taiwan and the United States, UNS was founded to address the social and economic burden of Alzheimer's and other neurodegenerative diseases and seeks to rapidly advance candidates into and through clinical trials with the goal of delivering breakthrough treatments to patients. For more information please visit www.unitedneuroscience.com. Follow UNS on Twitter at https://twitter.com/UNSTechBio and on LinkedIn at www.linkedin.com/company/unitedneuroscience.
SOURCE United Neuroscience, Ltd.